ADIPOQ and stroke disorder: Nagasawa et al. suggested that elevated plasma adiponectin levels may be a predictor of stroke mortality in the 17 months after an acute episode, while another study confirmed that adiponectin values may help classify stroke subtypes and predict the severity of neurological impairment and functional outcome in patients with ischemic stroke [47,49].